Descriptor English: | Phenytoin | ||||||
Descriptor Spanish: |
Fenitoína
| ||||||
Descriptor Portuguese: | Fenitoína | ||||||
Descriptor French: | Phénytoïne | ||||||
Entry term(s): |
5,5-Diphenylhydantoin 5,5-diphenylimidazolidine-2,4-dione Antisacer Difenin Dihydan Dilantin Diphenylhydantoin Diphenylhydantoinate, Sodium Epamin Epanutin Fenitoin Hydantol Phenhydan Phenytoin Sodium Sodium Diphenylhydantoinate |
||||||
Tree number(s): |
D03.383.129.308.432.555.730 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D010672 | ||||||
Scope note: | An anticonvulsant that is used to treat a wide variety of seizures. It is also an anti-arrhythmic and a muscle relaxant. The mechanism of therapeutic action is not clear, although several cellular actions have been described including effects on ion channels, active transport, and general membrane stabilization. The mechanism of its muscle relaxant effect appears to involve a reduction in the sensitivity of muscle spindles to stretch. Phenytoin has been proposed for several other therapeutic uses, but its use has been limited by its many adverse effects and interactions with other drugs. |
||||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
Pharm Action: |
Anticonvulsants Voltage-Gated Sodium Channel Blockers Cytochrome P-450 CYP1A2 Inducers |
||||||
Registry Number: | 6158TKW0C5 | ||||||
CAS Type 1 Name: | 2,4-Imidazolidinedione, 5,5-diphenyl- | ||||||
Public MeSH Note: | 78; was DIPHENYLHYDANTOIN 1963-77 |
||||||
Online Note: | use PHENYTOIN to search DIPHENYLHYDANTOIN 1966-77 |
||||||
History Note: | 78; was DIPHENYLHYDANTOIN 1963-77 |
||||||
DeCS ID: | 10867 | ||||||
Unique ID: | D010672 | ||||||
NLM Classification: | QV 85 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 1966/01/01 | ||||||
Date of Entry: | 1999/01/01 | ||||||
Revision Date: | 2017/06/29 |
-
-
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds
|
Phenytoin
- Preferred
Difenin
- Narrower
Dihydan
- Narrower
Phenytoin Sodium
- Narrower
Epamin
- Narrower
Epanutin
- Narrower
Hydantol
- Narrower
Antisacer
- Narrower
Dilantin
- Related but not broader or narrower
Phenhydan
- Narrower
Concept UI |
M0016580 |
Scope note | An anticonvulsant that is used to treat a wide variety of seizures. It is also an anti-arrhythmic and a muscle relaxant. The mechanism of therapeutic action is not clear, although several cellular actions have been described including effects on ion channels, active transport, and general membrane stabilization. The mechanism of its muscle relaxant effect appears to involve a reduction in the sensitivity of muscle spindles to stretch. Phenytoin has been proposed for several other therapeutic uses, but its use has been limited by its many adverse effects and interactions with other drugs. |
Preferred term | Phenytoin |
Entry term(s) |
5,5-Diphenylhydantoin 5,5-diphenylimidazolidine-2,4-dione Diphenylhydantoin Fenitoin |
Concept UI |
M0016582 |
Preferred term | Difenin |
Concept UI |
M0016581 |
Preferred term | Dihydan |
Concept UI |
M0016579 |
Preferred term | Phenytoin Sodium |
Entry term(s) |
Diphenylhydantoinate, Sodium Sodium Diphenylhydantoinate |
Concept UI |
M0016584 |
Preferred term | Epamin |
Concept UI |
M0353241 |
Preferred term | Epanutin |
Concept UI |
M0016585 |
Preferred term | Hydantol |
Concept UI |
M0353224 |
Preferred term | Antisacer |
Concept UI |
M0016583 |
Preferred term | Dilantin |
Concept UI |
M000747785 |
Preferred term | Phenhydan |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey